STORY SUMMARY
FDA warns of rare vision-loss side effect from GLP-1 drugs
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
This is a brief summary of reporting from CBS News U.S.. Read the original for the full article and context.